Guided Therapeutics Inc (GTHP) SEC Filing 8-K Material Event for the period ending Thursday, October 25, 2018

Guided Therapeutics Inc

CIK: 924515 Ticker: GTHP

View differences made from one to another to evaluate Guided Therapeutics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Guided Therapeutics Inc.


Assess how Guided Therapeutics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Guided Therapeutics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: GTHP
CIK: 924515
Form Type: 8-K Corporate News
Accession Number: 0001121781-18-000056
Submitted to the SEC: Thu Oct 25 2018 10:03:44 AM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Thursday, October 25, 2018
Industry: Electromedical And Electrotherapeutic Apparatus
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: